I relish the opportunity to work with companies operating in a range of different sectors and investment banks on high profile and innovative capital markets transactions.
ckeastbutler@cooley.com
Claire Keast-Butler’s practice focuses on capital markets transactions. She represents issuers, investment banks and investors on initial public offerings and secondary offerings. She also regularly advises listed companies on corporate and securities law matters and corporate governance, and has considerable experience in public and private mergers and acquisitions and general corporate matters.
Download full bio
Silence Therapeutics – $56.5 Million Registered Direct Offering
Biote Agrees to Combine With SPAC Haymaker Acquisition Corp. III
Alvotech Agrees to Merge With SPAC Oaktree Acquisition Corp. II
Rent the Runway – $357 Million IPO
Exscientia – $510.4 Million IPO
View all
Capital Markets
Public Companies
Mergers & Acquisitions
Life Sciences
Aviation – Manned & Unmanned
Claire Keast-Butler is described as very approachable, easy to talk to and very good on the technical side of things.
University College LondonLLB, Bachelors of LawHonors, 1998
England & Wales
HM Treasury Publishes UK Prospectus Regime Review Outcome March 8, 2022
Biote Agrees to Combine With SPAC Haymaker Acquisition Corp. III December 16, 2021
Alvotech Agrees to Merge With SPAC Oaktree Acquisition Corp. II December 9, 2021
UK Legal 500 - Leading Individual - Equity Capital Markets (2022)
+44 20 7556 4211
Locations